Spellman David A
Related Filers (2)
Ownership (15)
4
Thursday, 5/18/2023
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 3/3/2023
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/1/2023
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 2/2/2023
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/10/2022
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/2/2022
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/1/2021
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 4/1/2021
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 3/18/2021
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 3/2/2021
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/2/2020
Akebia Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/2/2020
Akebia Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 1/25/2019
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 3/14/2018
Mersana Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Wednesday, 3/14/2018
Mersana Therapeutics, Inc.: Statement of changes in beneficial ownership of securities